𝔖 Bobbio Scriptorium
✦   LIBER   ✦

305 RESULTS OF A MULTICENTRIC PHASE II RANDOMIZED TRIAL WITH DOCETAXEL (D) ± ESTRAMUSTINE (E) AS FIRST LINE CHEMOTHERAPY FOR PATIENTS (PTS) WITH HORMONE-REFRACTORY ADVANCED PROSTATE CANCER (HRPC)

✍ Scribed by O. Caffo; E. Comploj; T. Sava; G. Mansueto; F. Zustovich; R. Segati; C. Sacco; A. Perin; G. Pappagallo; F. Valduga; M. Frisinghelli; M. Centonze; E. Galligioni


Book ID
119617637
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
316 KB
Volume
6
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES